Nivolumab with peptide vaccine in patients naive to or that failed ipilimumab

Nivolumab blocking PD1 in lung cancer and melanoma

Selumetinib, the first effective drug for advanced melanoma of the eye

Ipilimumab and BRAF inhibitors for advanced melanoma

PDL1 inhibitors in melanoma

Comment on drug developments in advanced melanoma

Nivolumab produces long-lasting responses in patients with stage IV melanoma

New MEK inhibitor selumetinib is the first effective drug for advanced melanoma of the eye

Anti-PD-1 drug nivolumab shows high and durable clinical activity in patients with advanced melanoma

Adding GM-CSF to ipilimumab improves survival compared to ipilimumab alone

Prevention of squamous cell carcinoma

Immunotherapy in melanoma and other cancers